Editorial: Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes

Autor: Robert L. Hollis, Mignon D. J. M. van Gent

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

Externí odkaz: https://doaj.org/article/d85da56948ef457a9204c3dda6d147c4

Psychological impact of referral to an oncology hospital on patients with an ovarian mass

Autor: Pien Lof, Ellen G Engelhardt, Mignon D J M van Gent, Constantijne H Mom, Fleur M F Rosier-van Dunné, W Marchien van Baal, Harold R Verhoeve, Brenda B J Hermsen, Marjolijn B Verbruggen, Majoie Hemelaar, Jojanneke M G van de Swaluw, Haye C Knipscheer, Judith A F Huirne, Steven M Westenberg, Willemien J van Driel, Eveline M A Bleiker, Frédéric Amant, Christianne A R Lok

Publikováno v: International Journal of Gynecological Cancer, 33(1), 74-82. Wolters Kluwer Health
Lof, P, Engelhardt, E G, van Gent, M D J M, Mom, C H, Rosier-van Dunné, F M F, van Baal, W M, Verhoeve, H R, Hermsen, B B J, Verbruggen, M B, Hemelaar, M, van de Swaluw, J M G, Knipscheer, H C, Huirne, J A F, Westenberg, S M, van Driel, W J, Bleiker, E M A, Amant, F & Lok, C A R 2022, ' Psychological impact of referral to an oncology hospital on patients with an ovarian mass ', International Journal of Gynecological Cancer, vol. 33, no. 1, pp. 74-82 . https://doi.org/10.1136/ijgc-2022-003753
International journal of gynecological cancer, 33(1), 74-82. Wolters Kluwer Health

ObjectivesIn patients with an ovarian mass, a risk of malignancy assessment is used to decide whether referral to an oncology hospital is indicated. Risk assessment strategies do not perform optimally, resulting in either referral of patients with a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c09e832ee5d16636fa183a26da3da1
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85146016722&origin=inward

Improving response to progestin treatment of low-grade endometrial cancer

Autor: Andreas Obermair, Frédéric Amant, Michael A. Quinn, Shannon N. Westin, Camilla Krakstad, Jennifer J. Mueller, Jessica N. McAlpine, Donal J. Brennan, Mignon D. J. M. van Gent, Robert L. Coleman, David G. Huntsman, Melinda S. Yates, Monika Janda, Eva Baxter

Publikováno v: International Journal of Gynecological Cancer

ObjectivesThis review examines how response rates to progestin treatment of low-grade endometrial cancer can be improved. In addition to providing a brief overview of the pathogenesis of low-grade endometrial cancer, we discuss limitations in the cur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4a1d7869e04d8b4ee939519c85f890
https://doi.org/10.1136/ijgc-2020-001309

The origin of tumor DNA in urine of urogenital cancer patients: Local shedding and transrenal excretion

Autor: Renske D.M. Steenbergen, Jakko A. Nieuwenhuijzen, Rianne van den Helder, Mignon D. J. M. van Gent, Anouk E. Hentschel, Robert A. A. van Boerdonk, Annina P van Splunter, Nienke E. van Trommel

Publikováno v: Cancers, 13(3):535, 1-11. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Hentschel, A E, van den Helder, R, van Trommel, N E, van Splunter, A P, van Boerdonk, R A A, van Gent, M D J M, Nieuwenhuijzen, J A & Steenbergen, R D M 2021, ' The origin of tumor DNA in urine of urogenital cancer patients : Local shedding and transrenal excretion ', Cancers, vol. 13, no. 3, 535, pp. 1-11 . https://doi.org/10.3390/cancers13030535
Cancers, Vol 13, Iss 535, p 535 (2021)
Volume 13
Issue 3

Simple Summary There is a clinical need for non-invasive methods to detect urogenital cancer, for which urine offers a promising liquid biopsy. Tumor DNA in urine originates from shedding of the local tumor, but may also be excreted transrenally as c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::965929753d9d7e6202a04440fb57b146
https://research.vumc.nl/en/publications/2b7091a2-9970-4f56-aa84-80ba9d84a15f

Cervical cancer detection by DNA methylation analysis in urine

Autor: Nienke E. van Trommel, Maartje C van Ruiten, Mignon D. J. M. van Gent, W Frederik Rurup, Daniëlle A M Heideman, Wina Verlaat, Annina P van Splunter, Renske D.M. Steenbergen, Hans Schotman, Maaike C G Bleeker, Barbara C. Snoek

Publikováno v: Scientific reports, 9(1):3088. Nature Publishing Group
Scientific reports. Nature Publishing Group
Scientific Reports
Scientific Reports, 9(1). Nature Publishing Group
Snoek, B C, Splunter, A P V, Bleeker, M C G, Ruiten, M C V, Heideman, D A M, Rurup, W F, Verlaat, W, Schotman, H, Gent, M V, Trommel, N E V & Steenbergen, R D M 2019, ' Cervical cancer detection by DNA methylation analysis in urine ', Scientific Reports, vol. 9, no. 1, pp. 3088 . https://doi.org/10.1038/s41598-019-39275-2
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)

Urine samples provide a potential alternative to physician-taken or self-collected cervical samples for cervical screening. Screening by primary hrHPV testing requires additional risk assessment (so-called triage) of hrHPV-positive women. Molecular m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6cca324fd06c089547845efbe6a7c5
https://research.utwente.nl/en/publications/52f48137-a2ad-4452-b5bf-f76126f5dd17